Fasting blood glucose for insulin adjustment with insulin glargine or NPH insulin combined with sulphonylurea in Type 2 diabetes

被引：0

作者：

Haupt, A

Eckert, H

Schweitzer, MA

Peiker, J

Häring, HU

Fritsche, A

机构：

[1] Aventis Pharma Deutschland GmbH, Bad Soden am Taunus, Germany

[2] Univ Tubingen, Med Klin, D-7400 Tubingen, Germany

来源：

DIABETOLOGIA | 2004年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

743

引用

页码：A269 / A269

页数：1

共 50 条

[31] Effect of insulin degludec versus insulin glargine on glycaemic control and daily fasting blood glucose variability in insulin-naive Japanese patients with type 2 diabetes
Aso, Y.
Sakurai, S.
Iijima, T.
DIABETOLOGIA, 2017, 60 : S304 - S304
[32] Cost analysis of diabetes treatment with glargine insulin or NPH insulin in Spain
Rubio-Terrés, C
Rodriguez, J
Bolinder, B
VALUE IN HEALTH, 2003, 6 (03) : 336 - 336
[33] Fasting and insulin glargine in individuals with type 1 diabetes
Mucha, GT
Merkel, S
Thomas, W
Bantle, JP
DIABETES CARE, 2004, 27 (05) : 1209 - 1210
[34] Basal insulin therapy in type 2 diabetes - 28-week comparison of insulin glargine (HOE 901) and NPH insulin
Rosenstock, J
Schwartz, SL
Clark, CM
Park, GD
Donley, DW
Edwards, MB
DIABETES CARE, 2001, 24 (04) : 631 - 636
[35] Insulin Glargine (GLAR) and NPH Insulin (NPH) in Real Life in Russia in Patients with Type 2 Diabetes (T2D)
Shestakova, Marina V.
Glinkina, Irina V.
DIABETES, 2009, 58 : A530 - A530
[36] Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes
Schober, E
Schoenle, E
Van Dyk, J
Wernicke-Panten, K
DIABETES CARE, 2001, 24 (11) : 2005 - 2006
[37] Switch from NPH insulin to insulin glargine, in children and adolescents with type 1 diabetes mellitus
Spiteri, Anne
Fuzat, Laurent
Pradines, Sylvie
Garnier, Philippe E.
Papadimitriou, Dimitrios T.
HORMONE RESEARCH, 2006, 65 : 62 - 62
[38] A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes
Home, PD
Rosskamp, R
Forjanic-Klapproth, J
Dressler, A
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (06) : 545 - 553
[39] Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 2 diabetes in the UK
McEwan, Phil
Poole, Chris D.
Tetlow, Tony
Holmes, Paul
Currie, Craig J.
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S21 - S31
[40] Reproducibility of serum insulin and glucose infusion rate profiles of insulin glargine compared with NPH insulin and insulin ultralente
Scholtz, HE
Becker, RHA
DIABETOLOGIA, 2004, 47 : A273 - A273

← 1 2 3 4 5 →